levamlodipine: Clinical Trials

8 trials of levamlodipine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 2 unknown, 1 withdrawn. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 3, Not yet recruiting 2, Unknown 2, Withdrawn 1
Phase 21Completed 1

Follow levamlodipine: new trials by email Literature Review of levamlodipine trials Research Report on levamlodipine

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure.
Amlodipine - Hypertension, Oedema
Phase 3Not yet recruitingZentiva, k.s.3442026-11-302026-06-01
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients
SYH9056, Levamlodipine, Valsartan - Mild-to-moderate Essential Hypertension
Phase 3Not yet recruitingCSPC ZhongQi Pharmaceutical Technology Co., Ltd.6062025-01-242025-01-13
Efficacy and Safety of Leningrado Association in the Treatment of Hypertension
LENINGRADO association, Indapamide SR 1.5 MG, Levamlodipine 2.5/ 5 mg - Arterial Hypertension
Phase 3WithdrawnEMS2022-04-012022-07-27
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
AGSAVI, AGLS - Hypertension
Phase 3UnknownAhn-Gook Pharmaceuticals Co.,Ltd3062021-02-012020-12-29
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
TELMINUVO Tab. (80/2.5mg), TELMINUVO Tab. (80/5mg), S-amlodipine 2.5mg - Hypertension
Phase 3UnknownChong Kun Dang Pharmaceutical2002014-01-012013-11-14
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
CKD-828 2.5/40mg, CKD-828 5/40mg, CKD-828 5/80mg - Hypertension
Phase 3CompletedChong Kun Dang Pharmaceutical1032012-07-012013-06-21
CKD-828 S-Amlodipine Non-Responder Trial
CKD-828 2.5/40mg, CKD-828 2.5/80mg, S-Amlodipine 2.5mg - Hypertension
Phase 3CompletedChong Kun Dang Pharmaceutical1872011-08-012012-11-14
Anti Inflammatory Treatment of Hypertension
Levamlodipine, Amlodipine - Hypertension
Phase 2 / Phase 3CompletedAffiliated Hospital of North Sichuan Medical College2002010-05-012021-02-05

Conditions studied

Hypertension (7)  ·  Edema (1)  ·  Essential Hypertension (1)

Sponsors

Chong Kun Dang Pharmaceutical (3)  ·  Affiliated Hospital of North Sichuan Medical College (1)  ·  Ahn-Gook Pharmaceuticals Co.,Ltd (1)  ·  CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)  ·  EMS (1)  ·  Zentiva, k.s. (1)

Countries

South Korea (3)

Top investigators

Chang-kyu Park, Ph.D (1)  ·  Chul-ho Kim, Ph.D (1)  ·  Eun-joo Jo, Ph.D (1)  ·  Gyu-Rok Han, Ph.D (1)  ·  Ho-Joong Yoon, Ph.D (1)  ·  Jang-ho Bae, Ph.D (1)  ·  Jong-jin Kim, Ph.D (1)  ·  Sae-Joong Lim, Ph.D (1)  ·  Sang Hyun Kim, Ph.D (1)  ·  Tae-hoon An, Ph.D (1)  ·  Uk-Bum Phyun, Ph.D (1)  ·  Young-dae Kim, Ph.D (1)